Johnson Investment Counsel’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$478K Buy
11,209
+103
+0.9% +$4.6K ﹤0.01% 622
2026
Q1
$535K Sell
11,106
-726
-6% -$33.9K ﹤0.01% 564
2025
Q4
$573K Hold
11,832
﹤0.01% 519
2025
Q3
$558K Sell
11,832
-2,000
-14% -$96.5K ﹤0.01% 554
2025
Q2
$668K Buy
13,832
+1,736
+14% +$88.7K 0.01% 485
2025
Q1
$671K Sell
12,096
-1,750
-13% -$94.7K 0.01% 472
2024
Q4
$668K Sell
13,846
-701
-5% -$35.6K 0.01% 469
2024
Q3
$838K Buy
14,547
+4,288
+42% +$232K 0.01% 419
2024
Q2
$498K Sell
10,259
-312
-3% -$15.1K 0.01% 497
2024
Q1
$514K Sell
10,571
-398
-4% -$19.4K 0.01% 500
2023
Q4
$545K Buy
10,969
+3,514
+47% +$172K 0.01% 465
2023
Q3
$400K Buy
7,455
+148
+2% +$7.89K 0.01% 503
2023
Q2
$394K Buy
7,307
+2,018
+38% +$109K ﹤0.01% 516
2023
Q1
$288K Sell
5,289
-3,207
-38% -$156K ﹤0.01% 561
2022
Q4
$411K Sell
8,496
-78
-0.9% -$3.42K 0.01% 493
2022
Q3
$326K Buy
8,574
+78
+0.9% +$3.48K ﹤0.01% 519
2022
Q2
$425K Buy
8,496
+1,779
+26% +$94.4K 0.01% 480
2022
Q1
$345K Sell
6,717
-6,860
-51% -$354K ﹤0.01% 547
2021
Q4
$680K Buy
13,577
+107
+0.8% +$5.29K 0.01% 399
2021
Q3
$649K Sell
13,470
-9,006
-40% -$458K 0.01% 400
2021
Q2
$1.18M Sell
22,476
-1,278
-5% -$66.7K 0.02% 302
2021
Q1
$1.18M Sell
23,754
-1,850
-7% -$88.9K 0.02% 291
2020
Q4
$1.24M Sell
25,604
-1,295
-5% -$63.9K 0.02% 265
2020
Q3
$1.35M Sell
26,899
-465
-2% -$23.9K 0.03% 227
2020
Q2
$1.4M Sell
27,364
-2,305
-8% -$112K 0.03% 217
2020
Q1
$1.3M Sell
29,669
-3,010
-9% -$144K 0.03% 212
2019
Q4
$1.64M Sell
32,679
-332
-1% -$15.6K 0.03% 223
2019
Q3
$1.53M Buy
+33,011
New +$1.42M 0.03% 227
2019
Q1
Sell
-7,802
Closed -$338K 618
2018
Q4
$338K Sell
7,802
-154
-2% -$6.79K 0.01% 461
2018
Q3
$355K Sell
7,956
-87
-1% -$3.72K 0.01% 492
2018
Q2
$321K Buy
8,043
+25
+0.3% +$984 0.01% 506
2018
Q1
$321K Buy
8,018
+41
+0.5% +$1.71K 0.01% 513
2017
Q4
$343K Sell
7,977
-151
-2% -$6.96K 0.01% 501
2017
Q3
$404K Buy
8,128
+28
+0.3% +$1.35K 0.01% 458
2017
Q2
$388K Buy
+8,100
New +$387K 0.01% 468
2016
Q3
Sell
-5,453
Closed -$228K 585
2016
Q2
$228K Sell
5,453
-3,463
-39% -$142K 0.01% 505
2016
Q1
$358K Buy
8,916
+2,025
+29% +$81.4K 0.01% 405
2015
Q4
$293K Buy
6,891
+355
+5% +$16.3K 0.01% 436
2015
Q3
$310K Buy
+6,536
New +$333K 0.01% 427

Other funds holding SNY

Johnson Investment Counsel's SNY Position: Q2 2026 in Review

Johnson Investment Counsel increased its Sanofi (SNY) stake by 0.93% in Q2 2026, buying an estimated $4.6K and bringing the position to 11,209 shares worth $478K. The position accounts for ﹤0.01% of the portfolio, ranked #622.

Johnson Investment Counsel first reported a position in SNY in Q3 2015 and has held it in 39 quarters since. The position peaked at $1.64M in Q4 2019. 181 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Johnson Investment Counsel held 11,209 shares of Sanofi worth $478K as of Q2 2026.
  • Johnson Investment Counsel bought 103 Sanofi shares in Q2 2026, an estimated $4.6K.
  • Sanofi made up ﹤0.01% of Johnson Investment Counsel's portfolio in Q2 2026, its #622 holding.
  • Johnson Investment Counsel first reported a position in Sanofi in Q3 2015 and has held it in 39 quarters since.
  • Johnson Investment Counsel's Sanofi position peaked at $1.64M in Q4 2019.
  • 181 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Johnson Investment Counsel's 13F filing for Q2 2026, filed 23 Jul 2026.